AVITA Medical, Inc. (RCEL)
Largest Insider Buys in Sector
RCEL Stock Price History Chart
RCEL Stock Performance
About AVITA Medical, Inc.
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare …
Insider Activity of AVITA Medical, Inc.
Over the last 12 months, insiders at AVITA Medical, Inc. have bought $42,789 and sold $19,204 worth of AVITA Medical, Inc. stock.
On average, over the past 5 years, insiders at AVITA Medical, Inc. have bought $83,489 and sold $576,339 worth of stock each year.
Highest buying activity among insiders over the last 12 months: O'Toole David D (CFO) — $171,157.
The last purchase of 975 shares for transaction amount of $12,152 was made by O'Toole David D (CFO) on 2024‑12‑05.
List of Insider Buy and Sell Transactions, AVITA Medical, Inc.
| 2024-12-05 | CFO | 975 0.0037% | $12.46 | $12,152 | +1.85% | |||
| 2024-05-30 | CFO | 1,000 0.0037% | $8.90 | $8,900 | +10.45% | |||
| 2024-02-28 | CFO | 1,250 0.005% | $17.39 | $21,738 | -39.72% | |||
| 2023-12-26 | Sale | CEO | 1,445 0.0057% | $13.29 | $19,204 | -22.38% | ||
| 2023-12-21 | Sale | director | 2,500 0.01% | $12.49 | $31,225 | -14.06% | ||
| 2023-12-13 | Sale | director | 2,518 0.0095% | $12.27 | $30,896 | -17.57% | ||
| 2023-12-12 | CFO | 950 0.0039% | $12.45 | $11,828 | -11.27% | |||
| 2023-12-01 | CFO | 500 0.0019% | $10.68 | $5,340 | -4.36% | |||
| 2023-11-21 | CFO | 2,000 0.008% | $10.28 | $20,560 | +5.53% | |||
| 2023-11-16 | CFO | 1,000 0.0038% | $12.15 | $12,150 | -15.28% | |||
| 2023-11-15 | CFO | 2,000 0.0078% | $12.85 | $25,700 | -17.64% | |||
| 2023-11-15 | CFO | 1,000 0.0038% | $12.45 | $12,450 | -17.64% | |||
| 2023-11-14 | CFO | 1,000 0.0037% | $12.88 | $12,880 | -20.43% | |||
| 2023-08-21 | Sale | General Counsel | 4,193 0.0162% | $15.84 | $66,417 | -22.96% | ||
| 2023-08-16 | CFO | 2,000 0.0081% | $17.05 | $34,110 | -24.73% | |||
| 2023-08-15 | CFO | 5,000 0.0201% | $17.93 | $89,640 | -28.72% | |||
| 2023-06-20 | CFO | 1,000 0.004% | $16.15 | $16,150 | -11.58% | |||
| 2022-02-24 | Sale | Chief Executive Officer | 10,812 0.0423% | $8.74 | $94,497 | -27.15% | ||
| 2021-09-20 | director | 1,066 0.0043% | $17.08 | $18,207 | -50.62% | |||
| 2021-09-01 | Sale | Chief Executive Officer | 11,220 0.0447% | $20.68 | $232,030 | -57.95% |
Insider Historical Profitability
| O'Toole David D | CFO | 23734 0.0905% | $12.91 | 13 | 0 | <0.0001% |
| Crowe Suzanne | director | 4112 0.0157% | $12.91 | 1 | 0 | <0.0001% |
| McIntyre David | Chief Financial Officer | 893 0.0034% | $12.91 | 2 | 0 | <0.0001% |
Institutional Investor Ownership
| BlackRock | $28.05M | 6.78 | 1.75M | -3.13% | -$906,801.06 | <0.01 | |
| The Vanguard Group | $22.57M | 5.46 | 1.41M | +1.1% | +$246,156.68 | <0.0001 | |
| State Street | $15.08M | 3.65 | 941,041 | +88.09% | +$7.06M | <0.01 | |
| Geode Capital Management | $8.71M | 2.11 | 543,016 | +2.72% | +$230,207.68 | <0.01 | |
| Awm Investment Company Inc | $7.97M | 1.93 | 496,952 | 0% | +$0 | 1.21 |